Please assess the completion status of the following clinical trial:

Trial Title: Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Positive qualitative hepatitis C virus RNA test on two occasions at least 6 months apart~Exclusion Criteria:~* Heart rate \< 50/min,~* Taking amiodarone

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Subjects will receive sofosbuvir and daclatasvir

Based on this trial design, predict the completion outcome and termination type (if applicable).